ArticleScientific reports2026
A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate International Society of Urological Pathology (ISUP)-grade classification of renal cell carcinoma (RCC) is challenging due to subtle histopathological variations and the limitations of manual review. Existing deep learning models often rely on complex attention mechanisms that increase computational cost and hinder deployment. This study introduces a lightweight ResNet50V2-ECA framework that adds a single Efficient Channel Attention block after the final convolutional layer, enhancing channel-wise discrimination with minimal overhead (0.25 M parameters, 3.1 GFLOPs). Placing a single ECA block before GAP allows global channel recalibration after spatial feature extraction, avoiding the computational redundancy of multi-stage attention while preserving spatial resolution. Using the KMC kidney histopathology dataset (722 WSIs, 3,442 training patches across five grades), the model achieves 96.90% accuracy, 91.39% F1-score, and near-perfect AUC scores (Grade-0: 1.000; Grade-4: 0.997) across standard metrics (accuracy, precision, recall, F1, specificity, BAC, AUC). A comprehensive ablation study across five attention mechanisms (BAM, CBAM, SE, GC, ECA) and three backbones confirms that ResNet50V2-ECA yields the highest overall performance. Comparative analysis with leading RCC frameworks (RoCNN, EFF-Net, RCCGNet, RenalNet, MobileDANet) further demonstrates superior accuracy and efficiency. Model reliability is validated through a calibration diagram using Monte Carlo Dropout, showing strong alignment between predicted confidence and actual accuracy, while the risk-coverage curve reveals accuracy exceeding 99% when low-confidence cases are deferred. Together, these findings establish a high-precision, well-calibrated RCC grading system with strong potential for clinical deployment. While results indicate strong potential for clinical deployment, external multi-center validation is required to confirm generalizability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.